概述
华大基因是中国基因组学公司，提供基因检测、测序服务、科研服务和精准医学相关解决方案。
业务与产品
华大基因源于大规模基因组测序能力，业务涉及生育健康、肿瘤、感染防控、农业和科研服务等领域。
相关议题
在基因测序设备、试剂、数据分析和数据库体系上，华大基因代表中国生命科学产业链的重要本土力量。
关联实体与概念
来源与参考
-
The gene sequencing market landscape is changing! Domestic manufacturers welcome the opportunity of 100 billion substitutions, MGI may become the biggest winner — The gene sequencing market landscape is changing! Domestic manufacturers welcome the opportunity of 100 billion substitutions, MGI may become the biggest winner [...] The policy has hit hard, and Illumina has been banned altogether [...] On March 4, 2025, Chin
-
China’s Sequencing Landscape: New Players, New Dynamics, and What It Means for Illumina — The biggest change is that sequencing in China is no longer just a “best technology wins” decision. In my conversations with various Chinese biotech CEOs, lab directors and other key China-based stakeholders, it’s become clear choosing a sequencing platform pr
-
China’s Domestic Sequencers Take Bigger Market Share in First Half After Illumina Import Ban — Domestic Sequencers Take Bigger Market Share in First Half After Illumina [...] (Yicai) Sept. 11 -- The Chinese market share of domestically made genome-sequencing products has increased in the first half of the year, as the country imposed an import ban on US
-
raw/articles/笔记侠-特朗普访华CEO名单-2026.md— 该文章是本实体页创建或更新的来源之一。